Company / Debt per Share
Integra Lifesciences Holdings Debt per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$9.04
FY2025
5-year range
$9.04 / $9.76
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
#55 of 98
Health Care
What the data says
At $9.04, Integra Lifesciences Holdings's debt per share ranks #44 of 98 in the Health Care sector.
Based on SEC 10-K filings.
9.04 in FY2025 with a 5-year CAGR of -2.8%.
Remained stable around $9.04 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
#44 of 98 in Health CareTop 44% of 98This company $9.04 Sector average $46.19
▼
-80.4% below sector average
Key checks
Key Insights
- In FY2025, debt per share decreased 0.7% year-over-year.
- Ranks #55 out of 98 companies in the Health Care sector.
- Peak debt per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.04 | -0.7% |
| FY2024 | $9.11 | +0.4% |
| FY2023 | $9.07 | -0.3% |
| FY2022 | $9.09 | -6.8% |
| FY2021 | $9.76 | -6.6% |
| FY2020 | $10.45 | -5.8% |
| FY2019 | $11.09 | -2.4% |
| FY2018 | $11.36 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026